PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity

Barr, 2004, Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the US population, Environ Health Perspect, 112, 186, 10.1289/ehp.6503

Hill, 1995, Pesticide residues in urine of adults living in the United States: reference range concentrations, Environ Res, 71, 99, 10.1006/enrs.1995.1071

Loewenherz, 1997, Biological monitoring of organophosphorus pesticide exposure among children of agricultural workers in central Washington State, Environ Health Perspect, 105, 344, 10.1289/ehp.971051344

Simcox, 1999, Farmworker exposure to organophosphorus pesticide residues during apple thinning in central Washington State, Am Ind Hyg Assoc J, 60, 752, 10.1080/00028899908984498

Berkowitz, 2003, Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort, Environ Health Perspect, 111, 79, 10.1289/ehp.5619

Whyatt, 2003, Contemporary-use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns, Environ Health Perspect, 111, 749, 10.1289/ehp.5768

Eskenazi, 2003, CHAMACOS: a longitudinal birth cohort study: lessons from the fields, J Child Health, 1, 3, 10.3109/713610244

Bradman, 2003, Measurement of pesticides and other toxicants in amniotic fluid as a potential biomarker of prenatal exposure: a validation study, Environ Health Perspect, 111, 1782, 10.1289/ehp.6259

Castorina, 2003, Cumulative organophosphate pesticide exposure and risk assessment among pregnant women living in an agricultural community: a case study from the chamacos cohort, Environ Health Perspect, 111, 1642, 10.1289/ehp.5887

Fenske, 2002, Children's exposure to chlorpyrifos and parathion in an agricultural community in central Washington State, Environ Health Perspect, 110, 549, 10.1289/ehp.02110549

Sherman, 1995, Organophosphate pesticides – neurological and respiratory toxicity, Toxicol Ind Health, 11, 33, 10.1177/074823379501100103

Eskenazi, 1999, Exposures of children to organophosphate pesticides and their potential adverse health effects, Environ Health Perspect, 107, 409, 10.1289/ehp.99107s3409

Young, 2005, Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates, Neurotoxicology, 26, 199, 10.1016/j.neuro.2004.10.004

Garcia, 2005, Developmental neurotoxicity of chlorpyrifos: targeting glial cells, Env Toxicol Pharmacol, 19, 455, 10.1016/j.etap.2004.12.007

Moser, 1998, Age-and gender-related differences in the time-course of behavioral and biochemical effects produced by oral chlorpyrifos in rats, Toxicol Appl Pharmacol, 149, 107, 10.1006/taap.1997.8354

Sheets, 2000, A consideration of age-dependent differences in susceptibility to organophosphorus and pyrethroid insecticides, Neurotoxicology, 21, 57

Padilla, 2000, Comparison of the role of esterases in the differential age-related sensitivity to chlorpyrifos and methamidophos, Neurotoxicology, 21, 49

Zheng, 2000, Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats, Toxicol Sci, 55, 124, 10.1093/toxsci/55.1.124

Pope, 1991, Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides, Toxicology, 68, 51, 10.1016/0300-483X(91)90061-5

Chen, 2003, Increased influence of genetic variation on PON1 activity in neonates, Environ Health Perspect, 111, 1403, 10.1289/ehp.6105

Cole, 2003, Expression of human paraoxonase (PON1) during development, Pharmacogenetics, 13, 357, 10.1097/00008571-200306000-00007

Ecobichon, 1973, Perinatal development of human blood esterases, Clin Pharmacol Ther, 14, 41, 10.1002/cpt197314141

Mueller, 1983, Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies, Am J Hum Genet, 35, 393

Augustinsson, 1963, Age variation in plasma arylesterase activity in children, Clin Chim Acta, 8, 568, 10.1016/0009-8981(63)90106-2

Davies, 1996, The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin, Nat Genet, 14, 334, 10.1038/ng1196-334

Furlong, 1993, Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification, Chem Biol Interact, 87, 35, 10.1016/0009-2797(93)90023-R

Hassett, 1991, Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence, Biochemistry, 30, 10141, 10.1021/bi00106a010

Sorenson, 1999, Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity, Arterioscler Thromb Vasc Biol, 19, 2214, 10.1161/01.ATV.19.9.2214

Humbert, 1993, The molecular basis of the human serum paraoxonase activity polymorphism, Nat Genet, 3, 73, 10.1038/ng0193-73

Adkins, 1993, Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes, Am J Hum Genet, 52, 598

Li, 2000, Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds, Pharmacogenetics, 10, 767, 10.1097/00008571-200012000-00002

Brophy, 2001, Effects of 5′ regulatory region polymorphisms on paraoxonase (PON1) expression, Am J Hum Genet, 68, 1428, 10.1086/320600

Deakin, 2003, Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position 107, implicating the Sp1 transcription factor, Biochem J, 372, 643, 10.1042/bj20021670

Suehiro, 2000, A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression, Atherosclerosis, 150, 295, 10.1016/S0021-9150(99)00379-2

Li, 1993, Serum paraoxonase status: a major factor in determining resistance to organophosphates, J Toxicol Environ Health, 40, 337, 10.1080/15287399309531798

Richter, 1999, Determination of paraoxonase (PON1) status requires more than genotyping, Pharmacogenetics, 9, 745, 10.1097/00008571-199912000-00009

Jarvik, 2000, Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1 (192) or PON1 (55) genotype, Arterioscler Thromb Vasc Biol, 20, 2441, 10.1161/01.ATV.20.11.2441

Jarvik, 2003, Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status, Pharmacogenetics, 13, 291, 10.1097/00008571-200305000-00009

Leviev, 2001, Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations, J Lipid Res, 42, 528, 10.1016/S0022-2275(20)31161-5

Main, 1956, The role of A-esterase in the acute toxicity of paraoxon, TEPP and parathion, Can J Biochem Physiol, 34, 197, 10.1139/y56-023

Costa, 1990, Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats, Toxicol Appl Pharmacol, 103, 66, 10.1016/0041-008X(90)90263-T

Furlong, 1989, Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase, Anal Biochem, 180, 242, 10.1016/0003-2697(89)90424-7

Shih, 1998, Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis, Nature, 394, 284, 10.1038/28406

Li, 1995, Paraoxonase protects against chlorpyrifos toxicity in mice, Toxicol Lett, 76, 219, 10.1016/0378-4274(95)80006-Y

Cole, 2005, Toxicity of chlorpyriphos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism, Pharmacogenet Genom, 15, 589, 10.1097/01.fpc.0000167327.08034.d2

Brophy, 2002., Paraoxonase (PON1) in health and disease: basic and clinical aspects, 53

2002, Pesticide Use Reporting 2001 Summary Data: Department of Pesticide Regulation

Eskenazi, 2004, Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population, Environ Health Perspect, 112, 1116, 10.1289/ehp.6789

Blatter-Garin, 1994, Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations, Biochem J, 304, 549, 10.1042/bj3040549

2003, Stata Statistical Software: release 8.0

Berkowitz, 2004, In-utero exposure, maternal paraoxonase activity and head circumference, Environ Health Perspect, 112, 338, 10.1289/ehp.6414

Burlina, 1977, Characteristics and behaviour of arylesterase in human serum and liver, Eur J Clin Invest, 7, 17, 10.1111/j.1365-2362.1977.tb01564.x

Yuknavage, 1997, Simulated dermal contamination with capillary samples and field cholinesterase biomonitoring, J Toxicol Env Health, 51, 35

Huff, 1995, In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase, Neurotoxicology, 16, 281

Li, 1993, Dissertation: development of a mouse model for studying paraoxonase

Li, 1997, Paraoxonase (Pon1) gene in mice: sequencing, chromosomal location and developmental expression, Pharmacogenetics, 7, 137, 10.1097/00008571-199704000-00007

Moser, 1998, Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities, Toxicol Sci, 46, 211, 10.1093/toxsci/46.2.211

Hosokawa, 1995, Interindividual variation in carboxylesterase levels in human liver microsomes, Drug Metabol Dispos, 23, 1022

Wetmur, 2005, Molecular haplotyping by linking emulsion PCE: analysis of paraoxonase 1 haplotypes and phenotypes, Nucleic Acids Res, 33, 2615, 10.1093/nar/gki556

Timchalk, 2005, Pharmacokinetic and pharmacodynamic interaction for a binary mixture of chlorpyrifos and diazinon in the rat, Toxicol Appl Pharmacol, 205, 31, 10.1016/j.taap.2004.09.004

Draganov, 2005, Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities, J Lipid Res, 46, 1239, 10.1194/jlr.M400511-JLR200

Mackness, 2001, Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?, Atherscler Thromb Vasc Biol, 21, 1451, 10.1161/hq0901.094247

Mackness, 2004, Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?, Free Rad Biol Med, 37, 1317, 10.1016/j.freeradbiomed.2004.07.034